Ocular Therapeutix Inc. (OCUL)
6.28
-0.86 (-12.04%)
At close: Mar 03, 2025, 12:17 PM
Ocular Therapeutix Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 58.44M | 51.49M | 43.52M | 17.4M | 4.23M | 1.99M | 1.92M | 1.89M | 1.75M | 772K | n/a | 10K |
| Cost of Revenue | 5.28M | 4.54M | 4.41M | 2.08M | 2.33M | 465K | 457K | 443K | 319K | 91K | 10.52M | 7K |
| Gross Profit | 53.16M | 46.95M | 39.12M | 15.32M | 1.9M | 1.52M | 1.47M | 1.44M | 1.43M | 681K | -10.52M | 3K |
| Operating Income | -82.38M | -78.65M | -78.04M | -62.85M | -85.8M | -59.12M | -61.92M | -43.33M | -38.2M | -27.09M | -12.9M | -13.67M |
| Interest Income | 3.98M | 798K | 33K | 168K | 1.23M | 879K | 424K | 304K | 166K | 7K | 13K | 4K |
| Pretax Income | -80.74M | -71.04M | -6.55M | -155.64M | -86.37M | -59.98M | -63.39M | -44.7M | -39.75M | -28.65M | -13.32M | -14.09M |
| Net Income | -80.74M | -63.42M | -10.8M | -159.63M | -89.94M | -57.69M | -63.39M | -44.7M | -39.75M | -28.65M | -13.32M | -14.09M |
| Selling & General & Admin | 74.49M | 72.15M | 67.07M | 49.47M | 46.61M | 23.73M | 32.51M | 17.7M | 13.02M | 8.89M | 2.39M | 2.13M |
| Research & Development | 61.05M | 53.46M | 50.08M | 28.69M | 41.09M | 36.91M | 30.88M | 27.07M | 26.61M | 18.88M | 10.52M | 11.54M |
| Other Expenses | n/a | -1K | 1K | n/a | -8K | n/a | 5K | -1K | 7K | -442K | 14K | -49K |
| Operating Expenses | 135.54M | 125.61M | 117.15M | 78.17M | 87.7M | 60.64M | 63.39M | 44.77M | 39.63M | 27.77M | 12.9M | 13.67M |
| Interest Expense | 11.34M | 7.02M | 6.67M | 6.77M | 6.1M | 1.74M | 1.89M | 1.68M | 1.72M | 1.12M | 441K | 377K |
| Selling & Marketing Expenses | 40.55M | 39.92M | 35.19M | 26.61M | 24.49M | 4.94M | 17M | 6.7M | 3.85M | 1.98M | 625K | 657K |
| Cost & Expenses | 140.82M | 130.15M | 121.56M | 80.25M | 90.03M | 61.11M | 63.85M | 45.21M | 39.95M | 27.87M | 12.9M | 13.68M |
| Income Tax | n/a | -7.62M | 4.25M | 4M | 3.56M | -2.29M | 272K | 798K | 977K | 130K | 455K | 328K |
| Shares Outstanding (Basic) | 79.83M | 76.88M | 76.39M | 60.75M | 45.27M | 38.12M | 28.82M | 24.82M | 23.24M | 10.65M | 2.95M | 2.95M |
| Shares Outstanding (Diluted) | 85.6M | 76.88M | 82.16M | 60.75M | 45.27M | 38.12M | 28.82M | 24.82M | 23.24M | 10.65M | 2.95M | 2.95M |
| EPS (Basic) | -1.09 | -0.83 | -0.14 | -2.63 | -1.99 | -1.51 | -2.2 | -1.8 | -1.71 | -2.69 | -4.51 | -4.77 |
| EPS (Diluted) | -1.02 | -0.83 | -0.13 | -2.63 | -1.99 | -1.51 | -2.2 | -1.8 | -1.71 | -2.69 | -4.51 | -4.77 |
| EBITDA | -66.42M | -61.91M | -75.62M | -146.09M | -77.74M | -55.95M | -59.87M | -42.14M | -37.27M | -26.98M | -12.5M | -13.31M |
| Depreciation & Amortization | 2.98M | 2.11M | 2.42M | 2.77M | 2.53M | 2.29M | 1.63M | 881K | 754K | 547K | 404K | 404K |